Athenex, Inc.

/Athenex, Inc.

They are a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

Symbol

Last Closing Price
$15.47

Shares
4,300,000

Effective Date
January 25, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange